- Home
- NINE vs ACHL Comparison
NINE vs ACHL Comparison
Compare NINE & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NINE
- ACHL
- Stock Information
- Founded
- NINE 2011
- ACHL 2016
- Country
- NINE United States
- ACHL United Kingdom
- Employees
- NINE N/A
- ACHL N/A
- Industry
- NINE Oilfield Services/Equipment
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NINE Energy
- ACHL Health Care
- Exchange
- NINE Nasdaq
- ACHL Nasdaq
- Market Cap
- NINE 49.6M
- ACHL 46.0M
- IPO Year
- NINE 2018
- ACHL 2021
- Fundamental
- Price
- NINE $1.20
- ACHL $1.38
- Analyst Decision
- NINE
- ACHL Buy
- Analyst Count
- NINE 0
- ACHL 2
- Target Price
- NINE N/A
- ACHL $4.00
- AVG Volume (30 Days)
- NINE 1.1M
- ACHL 1.9M
- Earning Date
- NINE 03-05-2025
- ACHL 04-03-2025
- Dividend Yield
- NINE N/A
- ACHL N/A
- EPS Growth
- NINE N/A
- ACHL N/A
- EPS
- NINE N/A
- ACHL N/A
- Revenue
- NINE $556,751,000.00
- ACHL N/A
- Revenue This Year
- NINE N/A
- ACHL N/A
- Revenue Next Year
- NINE $3.95
- ACHL N/A
- P/E Ratio
- NINE N/A
- ACHL N/A
- Revenue Growth
- NINE N/A
- ACHL N/A
- 52 Week Low
- NINE $0.75
- ACHL $0.63
- 52 Week High
- NINE $3.26
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- NINE 48.24
- ACHL 72.41
- Support Level
- NINE $1.16
- ACHL $1.10
- Resistance Level
- NINE $1.24
- ACHL $1.41
- Average True Range (ATR)
- NINE 0.09
- ACHL 0.02
- MACD
- NINE -0.00
- ACHL 0.00
- Stochastic Oscillator
- NINE 58.58
- ACHL 90.48
About NINE Nine Energy Service Inc.
Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.